NO20015352L - Fremgangsmåte for å fremstille (IR,2S,4R)-(-)-2-[2'-{N,N- dimetylamino}-etoksy]-2-[fenyl]-1,7,7-tri[metyl]-bisyklo[2,2,1]heptan og farmasöytiskakseptable addisjonssalterderav - Google Patents

Fremgangsmåte for å fremstille (IR,2S,4R)-(-)-2-[2'-{N,N- dimetylamino}-etoksy]-2-[fenyl]-1,7,7-tri[metyl]-bisyklo[2,2,1]heptan og farmasöytiskakseptable addisjonssalterderav

Info

Publication number
NO20015352L
NO20015352L NO20015352A NO20015352A NO20015352L NO 20015352 L NO20015352 L NO 20015352L NO 20015352 A NO20015352 A NO 20015352A NO 20015352 A NO20015352 A NO 20015352A NO 20015352 L NO20015352 L NO 20015352L
Authority
NO
Norway
Prior art keywords
biscyclo
heptane
dimethylamino
ethoxy
tri
Prior art date
Application number
NO20015352A
Other languages
English (en)
Other versions
NO321487B1 (no
NO20015352D0 (no
Inventor
Gyula Lukacs
Gyula Simig
Tibor Mezei
Zoltan Budai
Marta Porcs-Makkay
Gyoergy Krasznai
Kalman Nagy
Gyoergy Vereczkeyne Donath
Tibor Szabo
Norbert Nemeth
Janos Szulagyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO20015352D0 publication Critical patent/NO20015352D0/no
Publication of NO20015352L publication Critical patent/NO20015352L/no
Publication of NO321487B1 publication Critical patent/NO321487B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/12—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015352A 1999-05-11 2001-11-01 Fremgangsmate for a fremstille (IR,2S,4R)-(-)-2-[2'-{N,N-dimetylamino}-etoksy]-2-[fenyl]-1,7,7-tri[metyl]-bisyklo[2,2,1]heptan og farmasoytiskakseptable addisjonssalter derav NO321487B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9901559A HU227114B1 (en) 1999-05-11 1999-05-11 (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
PCT/HU2000/000043 WO2000068181A2 (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof

Publications (3)

Publication Number Publication Date
NO20015352D0 NO20015352D0 (no) 2001-11-01
NO20015352L true NO20015352L (no) 2002-01-08
NO321487B1 NO321487B1 (no) 2006-05-15

Family

ID=89998272

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20015336A NO321486B1 (no) 1999-05-11 2001-10-31 (IR,2S,4R)-(-)-2-[(2'-{N,N-dimetylamino}-etoksy)]-2-[fenyl]-1,7,7-tri-[metyl]-bisyklo[2,2,1]heptan med hoy renhet og farmasoytisk akseptable syreaddisjonssalt derav og en fremgangsmate til fremstilling av disse forbindelser, sa vel som legemidler som inneholder en eller flere av disse forbindelser og deres anvendelser.
NO20015352A NO321487B1 (no) 1999-05-11 2001-11-01 Fremgangsmate for a fremstille (IR,2S,4R)-(-)-2-[2'-{N,N-dimetylamino}-etoksy]-2-[fenyl]-1,7,7-tri[metyl]-bisyklo[2,2,1]heptan og farmasoytiskakseptable addisjonssalter derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20015336A NO321486B1 (no) 1999-05-11 2001-10-31 (IR,2S,4R)-(-)-2-[(2'-{N,N-dimetylamino}-etoksy)]-2-[fenyl]-1,7,7-tri-[metyl]-bisyklo[2,2,1]heptan med hoy renhet og farmasoytisk akseptable syreaddisjonssalt derav og en fremgangsmate til fremstilling av disse forbindelser, sa vel som legemidler som inneholder en eller flere av disse forbindelser og deres anvendelser.

Country Status (38)

Country Link
US (3) US6242386B1 (no)
EP (4) EP1052245B1 (no)
JP (2) JP4031203B2 (no)
KR (3) KR100685071B1 (no)
CN (2) CN1173928C (no)
AR (2) AR023900A1 (no)
AT (4) ATE237579T1 (no)
AU (2) AU776696B2 (no)
BG (2) BG64442B1 (no)
BR (2) BR0010412A (no)
CA (2) CA2369393C (no)
CO (1) CO5170480A1 (no)
CZ (4) CZ20014051A3 (no)
DE (4) DE60006097T2 (no)
DK (4) DK1177166T3 (no)
EA (2) EA002163B1 (no)
EE (2) EE200100596A (no)
ES (4) ES2194643T3 (no)
FR (2) FR2793490B1 (no)
HK (2) HK1031220A1 (no)
HR (2) HRP20000290B1 (no)
HU (1) HU227114B1 (no)
IL (4) IL146420A0 (no)
IS (2) IS2570B (no)
LT (2) LT4928B (no)
MX (2) MXPA01011423A (no)
MY (2) MY123523A (no)
NO (2) NO321486B1 (no)
NZ (2) NZ515918A (no)
PL (2) PL340107A1 (no)
PT (4) PT1177166E (no)
SI (4) SI1052245T1 (no)
SK (4) SK6902000A3 (no)
TR (2) TR200200147T2 (no)
TW (2) TW528742B (no)
UA (2) UA61122C2 (no)
WO (2) WO2000068181A2 (no)
ZA (2) ZA200108958B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6589996B2 (en) 2000-03-17 2003-07-08 Orion Corporation Treatment of disorders relating to the serotonergic system
US20040082665A1 (en) * 2001-01-22 2004-04-29 Outi Maki-Ikola Method for treating stress or tension
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
AU2004317128A1 (en) * 2004-03-12 2005-09-22 Egis Gyogyszergyar Nyrt Combination of deramciclane and opoids as analgesics
JP4916680B2 (ja) * 2005-06-30 2012-04-18 株式会社半導体エネルギー研究所 半導体装置の作製方法、剥離方法
US20080258121A1 (en) * 2007-04-23 2008-10-23 Hasan Farooq Fire Retardant Composition
RU2578715C2 (ru) 2009-11-19 2016-03-27 Йиссум Рисерч Дивелопмент Компани Оф Дзе Хебрю Юниверсити Оф Иерусалим, Лтд. Новые арилированные камфены, способы их получения и их применения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU212574B (en) * 1990-09-21 1996-08-29 Egyt Gyogyszervegyeszeti Gyar Process for producing (1r,2s)-(-)-2-phenyl-(2'-dimethyl-amino-etoxy)-1,7,7-trimethyl-bicyclo[2.2.1.]heptane
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
HU226061B1 (en) 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Also Published As

Publication number Publication date
EA002163B1 (ru) 2001-12-24
SK16232001A3 (sk) 2002-04-04
SI1177167T1 (en) 2004-04-30
KR20020010914A (ko) 2002-02-06
PL340108A1 (en) 2000-11-20
BG104416A (en) 2001-03-30
EP1052243A2 (en) 2000-11-15
MY123523A (en) 2006-05-31
EP1052243B1 (en) 2003-07-30
SK6902000A3 (en) 2000-12-11
NZ515918A (en) 2004-02-27
EA002164B1 (ru) 2001-12-24
HU9901559D0 (en) 1999-07-28
DK1052245T3 (da) 2003-08-11
CZ20001722A3 (cs) 2000-12-13
NO20015336L (no) 2002-01-08
TR200200147T2 (tr) 2002-06-21
FR2793490B1 (fr) 2004-04-23
FR2793490A1 (fr) 2000-11-17
DE60006097T2 (de) 2004-06-17
KR20060010874A (ko) 2006-02-02
IL146420A0 (en) 2002-07-25
TWI286541B (en) 2007-09-11
AU4773100A (en) 2000-11-21
CZ20014050A3 (cs) 2002-05-15
SK285780B6 (sk) 2007-08-02
JP2002544184A (ja) 2002-12-24
FR2793489B1 (fr) 2004-04-02
WO2000068181A3 (en) 2001-06-28
CA2369393C (en) 2010-07-06
UA49974C2 (uk) 2002-10-15
EA200000410A2 (ru) 2000-12-25
DK1177166T3 (da) 2008-06-16
HRP20000290B1 (en) 2007-08-31
DE60004126T2 (de) 2004-04-22
FR2793489A1 (fr) 2000-11-17
BG104417A (en) 2001-03-30
MXPA01011423A (es) 2002-06-04
LT4928B (lt) 2002-07-25
NO321487B1 (no) 2006-05-15
HRP20000291A2 (en) 2001-06-30
MY122508A (en) 2006-04-29
CZ20014051A3 (cs) 2002-05-15
EP1177167B1 (en) 2003-10-22
EP1177166A2 (en) 2002-02-06
EP1177167A2 (en) 2002-02-06
HRP20000290A2 (en) 2005-02-28
WO2000068181A2 (en) 2000-11-16
BR0010412A (pt) 2002-02-13
EE200100595A (et) 2003-02-17
KR100581489B1 (ko) 2006-05-22
UA61122C2 (uk) 2003-11-17
TR200200148T2 (tr) 2002-06-21
PL340107A1 (en) 2000-11-20
AR023900A1 (es) 2002-09-04
HK1031220A1 (en) 2001-06-08
PL202956B1 (pl) 2009-08-31
NO20015336D0 (no) 2001-10-31
CZ290734B6 (cs) 2002-10-16
EE200100596A (et) 2003-02-17
SK16242001A3 (sk) 2002-04-04
ES2208328T3 (es) 2004-06-16
DE60002117T2 (de) 2003-12-24
NO20015352D0 (no) 2001-11-01
ES2203373T3 (es) 2004-04-16
HK1031372A1 (en) 2001-06-15
US20020040164A1 (en) 2002-04-04
JP2002544185A (ja) 2002-12-24
ATE237579T1 (de) 2003-05-15
CA2373193A1 (en) 2000-11-16
NO321486B1 (no) 2006-05-15
SK285635B6 (sk) 2007-05-03
PT1177166E (pt) 2008-06-02
DE60006097D1 (de) 2003-11-27
EE04672B1 (no) 2006-08-15
EA200000410A3 (ru) 2001-02-26
WO2000068183A3 (en) 2001-07-26
IS2570B (is) 2010-01-15
ZA200108956B (en) 2003-02-17
JP4031203B2 (ja) 2008-01-09
DE60002117D1 (de) 2003-05-22
DK1177167T3 (da) 2004-03-01
IL146421A (en) 2008-11-26
EP1052243A3 (en) 2001-02-28
CO5170480A1 (es) 2002-06-27
US6242386B1 (en) 2001-06-05
PT1052243E (pt) 2003-12-31
EP1052245A2 (en) 2000-11-15
EA200000411A2 (ru) 2000-12-25
ZA200108958B (en) 2002-10-30
EP1052245B1 (en) 2003-04-16
SI1177166T1 (sl) 2008-08-31
SI1052245T1 (en) 2003-10-31
US6624201B2 (en) 2003-09-23
EE04638B1 (et) 2006-06-15
JP4536265B2 (ja) 2010-09-01
CN1353686A (zh) 2002-06-12
CN1173928C (zh) 2004-11-03
CZ20001723A3 (cs) 2000-12-13
EP1177166B1 (en) 2008-02-20
EA200000411A3 (ru) 2001-02-26
DE60038112T2 (de) 2009-02-12
CA2369393A1 (en) 2000-11-16
TW528742B (en) 2003-04-21
DE60004126D1 (de) 2003-09-04
HRP20000291B1 (en) 2005-06-30
US6335469B1 (en) 2002-01-01
SK6892000A3 (en) 2000-12-11
AU4600300A (en) 2000-11-21
LT2001108A (en) 2002-03-25
DE60038112T8 (de) 2009-05-28
IS6153A (is) 2001-11-09
ATE246170T1 (de) 2003-08-15
HU227114B1 (en) 2010-07-28
AU777737B2 (en) 2004-10-28
AU776696B2 (en) 2004-09-16
HUP9901559A2 (hu) 2002-01-28
DK1052243T3 (da) 2003-11-24
LT4927B (lt) 2002-07-25
BG64673B1 (bg) 2005-11-30
IL146421A0 (en) 2002-07-25
PT1052245E (pt) 2003-09-30
IS6152A (is) 2001-11-09
AR020860A1 (es) 2002-05-29
ES2194643T3 (es) 2003-12-01
DE60038112D1 (de) 2008-04-03
BR0010406A (pt) 2002-02-13
BG64442B1 (en) 2005-02-28
CN1353687A (zh) 2002-06-12
CZ291329B6 (cs) 2003-02-12
MXPA01011420A (es) 2002-06-04
ES2302694T3 (es) 2008-08-01
LT2001109A (en) 2002-03-25
IL146420A (en) 2007-06-03
KR20010112486A (ko) 2001-12-20
WO2000068183A2 (en) 2000-11-16
KR100685071B1 (ko) 2007-02-22
SI1052243T1 (en) 2004-02-29
CN1325465C (zh) 2007-07-11
ATE386714T1 (de) 2008-03-15
EP1052245A3 (en) 2001-02-28
ATE252544T1 (de) 2003-11-15
PT1177167E (pt) 2004-03-31
NZ515917A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
IL151202A0 (en) Phenyl derivatives, a process for their praparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy
SI1158992T1 (en) Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications
HUP0201637A3 (en) Novel preparation and administration form comprising an acid-labile active compound
HUP0301447A3 (en) Combined pharmaceutical compositions containing tiotropium and salmeterol salts
NO20015352L (no) Fremgangsmåte for å fremstille (IR,2S,4R)-(-)-2-[2'-{N,N- dimetylamino}-etoksy]-2-[fenyl]-1,7,7-tri[metyl]-bisyklo[2,2,1]heptan og farmasöytiskakseptable addisjonssalterderav
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
HUP0500958A3 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
IL150403A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
EP1245562A4 (en) ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT.
AU7008900A (en) N-substituted norephedrine chiral derivatives, their preparation and their use for the synthesis of optically active functionalised compounds by hydrogen transfer
SI1283845T1 (en) Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
GB9918762D0 (en) Analgesic/anaesthetic formulation